Yahoo Finance Arm, AMD, Micron, Cisco, and Other Tech Stocks in Focus Today
Tech companies were struggling for direction early Thursday as the Nasdaq Composite Index tried once again to snap its losing streak.
Tech companies were struggling for direction early Thursday as the Nasdaq Composite Index tried once again to snap its losing streak.
The asylum seeker went to the east Africa country under a scheme separate to the forced returns scheme.
Q1 2024 Transmedics Group Inc Earnings Call
BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. as interim CEO. Rachelle Jacques will step down as Akari’s Chief Executive Officer effective today. Melissa Bradford-Klug will step down as Akari’s Chief Operating Officer effective today
– Josh Rosen to shed Interim title and become Chief Executive Officer; Company provides other key personnel updates – – Company receives a short-term extension of the maturity date on its credit facility – – Company plans corporate name change to Vireo – MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), today announced several leadership and corporate updates related to the day-to-day management of its bus
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences: Bank of America Securities Healthcare Conference – May 14-16, 202452nd Annual JP Morgan Global Technology Conference – May 20-22, 2024 About Recursion Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug disc
The market rally stumbled ahead of the Fed meeting. Amazon rose on earnings while AI plays Super Micro and AMD plunged.
May is here. Tempted to sell your S&P 500 stocks and go away until November? You might be missing out on some strong gains.
Live Nation's Concert Week is offering hundreds of shows with $25 all-in tickets. Check out the list of available concerts.
Collaborative research with clinical trial professionals identifies ways eCOA can contribute to faster neurological breakthroughsMALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today announced the availability of a new report, Insights into CNS Clinical Trials, which provides clinical trial sponsors with data-driven insights on how electronic clinical outcome assessments (eCOA) can improve Central Nervous System (CNS) trial efficiency and
Prioritization of Peak’s ADC cancer therapeutic platform technology and Akari’s PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic diseaseAkari Therapeutics announces leadership changes in separate Akari press release BOSTON and PLEASANTON, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX, “Akari”) and Peak Bio Inc. (OTC: PKBO, “Peak”) today announced completion of a joint portfolio prioritization review pursuant to which the combined entity, following com
PLANO, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Tuesday, May 14, at 10:40 a.m. PDT. A live webcast of the presentation will be accessible under “New
SAN FRANCISCO, May 01, 2024 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company dedicated to the development of novel therapeutics for the treatment of immunological diseases with high unmet medical needs, today announced that management will participate in the following May 2024 medical conferences: The Annual Meeting of the American Association of Immunologists (AAI) – Immunology 2024Title: Funding Spotlight: Translating Academic Research to Indust
NORWOOD, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a panel discussion as part of the BTIG Obesity Health Forum, to be held virtually on May 8, 2024. Details of the panel discussion are as follow: BTIG Obesity Health ForumPanel Title: CB1 Axis Therapies for ObesityDate: Wednesday, May 8, 2024Presentation Time: 3:00 p.m. ET
on|comms empowers veterans with digital inclusion through mobile connectivity, educational initiatives and reintegration services. Enabled with Optiva BSS data, on|comms will use predictive analytics to proactively identify at-risk service members, addressing the essential needs of veterans.TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- on|comms has chosen Optiva (TSX: OPT) BSS platform, hosted on Google Cloud, to provide mobile connectivity to its members with the launch of a new MVNO service. on|co
Largest Medical School in Nevada Provides Every Student with Wireless, Portable UltrasoundSAN JOSE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Vave Health, the company on a mission to put ultrasound in every medical professional’s pocket, today announced that Touro University Nevada College of Osteopathic Medicine (TUNCOM) is now providing all medical students with a Vave point-of-care ultrasound (POCUS) device as part of their standard doctor of osteopathic medicine (DO) curriculum. TUNCOM is usi
- CX-904 (masked EGFRxCD3 Probody® T-cell engager) preliminary Phase 1a results to be presented from ongoing dose escalation study - - Management to hold conference call at 5 p.m. EDT / 2 p.m. PDT on May 8th- SOUTH SAN FRANCISCO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that it will report first quarter 2024 results and provide an initial CX-904 Phase 1a dose
SOUTH SAN FRANCISCO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced participation in the following May investor events. RBC Capital Markets Global Healthcare Conference Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer,
RESEARCH TRIANGLE PARK, N.C., May 01, 2024--Worldwide Clinical Trials recognized for excellence in the 2024 CRO Leadership Awards for the 11th consecutive year.
Company Shifting Focus from Technology Startup to Product Driven ScaleupVANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company developing next-generation intelligent software systems, announces that Hari Thiruvengada has been promoted to Chief Product Officer as the Company aggressively focuses on shipping its flagship product, Genius™. Dr. Thiruvengada was previously VP of Product and the